Search results
Latest Market News Today Live Updates July 10, 2024: Fed's Powell says not ready yet to declare...
Livemint· 12 hours agoLatest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your...
Emcure Pharma closes 3% higher after making strong market debut; should you buy the stock now? |...
Livemint· 19 hours agoEmcure Pharma’s IPO saw strong investor interest, with oversubscription rates of 67.87 times....
Bansal Wire share price falls marginally post robust listing. Should you hold or exit? - The...
The Economic Times· 20 hours agoBansal Wire Industries made a strong debut in the bourses on Wednesday, garnering a premium of 39%...
Emcure Pharma shares jump over 4% post listing. Should you buy, sell or hold? - The Economic Times
The Economic Times· 22 hours agoThe stock is listed at Rs 1325 on NSE and BSE over the IPO price of Rs 1008 apiece, a premium of Rs 317 or 31.4% as against the issue price. The enthusiastic listing was kind of expected after ...
Bansal Wire shares up 33% after a strong listing; Should investors buy, sell or hold? | Stock Market...
Livemint· 23 hours agoBansal Wire share price was listed with a 37.52 per cent premium at ₹352.05 per share on the BSE,...
Bansal Wire Industries IPO Makes Stellar Market Debut With 39.4% Gains: Should Investors Hold, Sell...
News18· 1 day agoBansal Wire Industries IPO Listing: Bansal Wire Industries' stock listed on the BSE at Rs 356, which...
Bansal Wire makes stellar debut; lists at 39% premium over issue price
Business Standard India· 1 day agoThe stock listed at Rs 356, a 39 per cent premium over its issue price of Rs 256 per share on the...
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 1 day agoEmcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a...
Bansal Wire shares list at nearly 40% premium: Should you hold or sell? - CNBC TV18
CNBC TV18· 1 day agoBansal Wire Industries Ltd. made a stellar debut on the stock exchanges on Wednesday, July 10, surpassing even optimistic pre-listing forecasts. Similarly, the stock started trading at ₹352.05 on the BSE, a premium of 38%.
Emcure Pharma IPO Listing: Shares debut at nearly 32% premium over IPO price - CNBC TV18
CNBC TV18· 1 day agoIn fact, the debut price on July 10 (Wednesday) was similar to analysts' expectations as well the grey market investors quoted. Last heard, shares of Emcure Pharmaceuticals were commanding a ...